Select Medical Holdings Corp

Select Medical Holdings Corp(SEM)股票分析

$16.510

-0.020 (-0.12%)收盤時

Loading chart…
最高
16.560
開盤
16.530
成交量加權均價
16.53
成交量
27.84M
市值
4.56B
最低
16.510
成交金額
460.09M
企業價值/稅息折舊攤銷前利潤(TTM)
9.06

Select Medical Holdings Corporation operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. Its segments include Critical Illness Recovery Hospital, Rehabilitation Hospital, and Outpatient Rehabilitation. Critical Illness Recovery Hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. It operates the majority of its critical illness recovery hospitals as a hospital within a hospital (an HIH). Rehabilitation Hospital segment serves patients that require intensive physical rehabilitation care. Outpatient Rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. It operates around 105 critical illness recovery hospitals in 29 states, 36 rehabilitation hospitals in 14 states, and 1,922 outpatient rehabilitation clinics in 39 states and the District of Columbia.

AI 分析 of Select Medical Holdings Corp (SEM)

持有

Select Medical Holdings Corp (SEM) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock is being acquired for $16.50 per share in cash, effectively capping its upside potential. Additionally, there are no significant trading signals or positive catalysts to suggest a compelling entry point.

分析師評級(6)

上檔空間 +13.57%
買進
4 買進
0 持有
2 賣出
目前: 16.51
最低
17.00
平均
18.75
最高
21.00

Mizuho

2026-05-12

目標價

$17

中性

RBC Capital

2026-02-23

目標價

$19

優於大盤

BofA

2025-11-25

目標價

—

No Rating

BofA

2025-09-10

目標價

$15

買進

UBS

2025-08-04

目標價

$14

中性

估值指標

Select Medical Holdings Corp(SEM)目前預期本益比為 13.42,5 年平均預期本益比為 13.78。

預期本益比

合理
5 年均值 P/E
13.78
目前P/E
13.42
高估
16.29
低估
11.27

預期 EV/EBITDA

低估
5 年均值 EV/EBITDA
10.31
目前EV/EBITDA
9.06
高估
11.33
低估
9.30

預期股價營收比

低估
5 年均值 P/S
0.47
目前P/S
0.34
高估
0.59
低估
0.36

Alphio AI 對 SEM 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%SEM

$15.70

情境價格

基

基準

基準 · 50%SEM

$13.55

情境價格

悲

悲觀

悲觀 · 25%SEM

$11.91

情境價格

持有 SEM 的大戶

E

Eversept Partners, L.P.

+ 持有SEM

-7.76%

3個月報酬率

事件時間軸

2026-06-30 (ET)

16:30:00

Select Medical Completes Acquisition, Ceases Trading

2026-06-26 (ET)

17:30:00

Select Medical Holdings to be Acquired

2026-05-21 (ET)

09:10:00

Select Medical and Carilion Clinic Partner to Build 50-Bed Rehab Hospital

2026-04-30 (ET)

16:50:00

Sees FY25 Adjusted EBITDA at $520M-$540M

16:40:00

Company Reports Q1 Revenue of $1.421B

資訊

SEM 常見問題 —— 由 Alphio AI 解答

Select Medical Holdings Corporation operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. Its segments include Critical Illness Recovery Hospital, Rehabilitation Hospital, and Outpatient Rehabilitation. Critical Illness Recovery Hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. It operates the majority of its critical illness recovery hospitals as a hospital within a hospital (an HIH). Rehabilitation Hospital segment serves patients that require intensive physical rehabilitation care. Outpatient Rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. It operates around 105 critical illness recovery hospitals in 29 states, 36 rehabilitation hospitals in 14 states, and 1,922 outpatient rehabilitation clinics in 39 states and the District of Columbia. It operates in the Healthcare sector (SERVICES-HOSPITALS industry).

Select Medical Holdings Corp (SEM) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock is being acquired for $16.50 per share in cash, effectively capping its upside potential. Additionally, there are no significant trading signals or positive catalysts to suggest a compelling entry point.

6 analysts cover SEM: 4 rate it Buy, 0 Hold and 2 Sell. The average price target is 18.75.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易